Women's Sex Drive Pill Is Defended by FDA, With CaveatsBy
Addyi approved in August, sold by Valeant Pharmaceuticals
Agency officials say women should be able to decide on drug
Approving a pill to boost women’s sex drive was the right decision and patients should be able to make their own call about taking it, the U.S. Food and Drug Administration said in an essay defending the agency’s move in a leading medical journal.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.